Oligodendrocyte subtype diversity underlines clinical progression in Parkinsons disease
Daniela Mîrzac, Nils Schroeter, Yann Decker, Martin B. Glaser, Matthias J. M. Huelser, Svenja L. Kreis, Heiko J. Luhmann, Viviane Almeida, Jenny Blech, Sebastian Kunz, Matthias Klein, Tobias Bopp, Michael Thomas Heneka, Philip L. De Jager, Joachim Oertel, , Sergiu Groppa
The paper identifies oligodendrocyte subtype changes in Parkinson's disease across species, linking them to disease progression and clinical outcomes.
bioRxiv · May 18, 2026 · PreprintNeuroscience